Early and late administration of MnTE-2-PyP5+ in mitigation and treatment of radiation-induced lung damage - PubMed (original) (raw)
Early and late administration of MnTE-2-PyP5+ in mitigation and treatment of radiation-induced lung damage
Benjamin Gauter-Fleckenstein et al. Free Radic Biol Med. 2010.
Abstract
Chronic production of reactive oxygen and nitrogen species is an underlying mechanism of irradiation (IR)-induced lung injury. The purpose of this study was to determine the optimum time of delivery of an antioxidant and redox-modulating Mn porphyrin, MnTE-2-PyP(5+), to mitigate and/or treat IR-induced lung damage. Female Fischer-344 rats were irradiated to their right hemithorax (28 Gy). Irradiated animals were treated with PBS or MnTE-2-PyP(5+) (6 mg /kg/24 h) delivered for 2 weeks by sc-implanted osmotic pumps (beginning after 2, 6, 12, 24, or 72 h or 8 weeks). Animals were sacrificed 10 weeks post-IR. Endpoints were body weight, breathing frequency, histopathology, and immunohistochemistry (8-OHdG, ED-1, TGF-beta, HIF-1alpha, VEGF A). A significant radioprotective effect on functional injury, measured by breathing frequency, was observed for all animals treated with MnTE-2-PyP(5+). Treatment with MnTE-2-PyP(5+) starting 2, 6, and 12 h but not after 24 or 72 h resulted in a significant decrease in immunostaining for 8-OHdG, HIF-1alpha, TGF-beta, and VEGF A. A significant decrease in HIF-1alpha, TGF-beta, and VEGF A, as well as an overall reduction in lung damage (histopathology), was observed in animals beginning treatment at the time of fully developed lung injury (8 weeks post-IR). The catalytic manganese porphyrin antioxidant and modulator of redox-based signaling pathways MnTE-2-PyP(5+) mitigates radiation-induced lung injury when given within the first 12 h after IR. More importantly, this is the first study to demonstrate that MnTE-2-PyP(5+) can reverse overall lung damage when started at the time of established lung injury 8 weeks post-IR. The radioprotective effects are presumably mediated through its ability both to suppress oxidative stress and to decrease activation of key transcription factors and proangiogenic and profibrogenic cytokines.
Copyright 2010 Elsevier Inc. All rights reserved.
Figures
Figure 1
Breathing frequencies, as recorded bi-weekly from week zero (pre-IR) to week ten (time-point of sacrifice). In comparison to nonirradiated control animals, significantly higher breathing rates were measured in animals which received no treatment after IR (P = 0.0079). Animals, which were irradiated and received MnTE-2-PyP5+ post-IR displayed significantly lower breathing rates in comparison to the IR-only group. Animals, which received late treatment starting 8 weeks post-IR displayed a trend towards elevated breathing frequencies which was not more seen 5 days after starting of treatment (implantation of pumps at day 5 of week 7; measurement of breathing frequencies five days later at day 3 of week 8).
Figure 1
Breathing frequencies, as recorded bi-weekly from week zero (pre-IR) to week ten (time-point of sacrifice). In comparison to nonirradiated control animals, significantly higher breathing rates were measured in animals which received no treatment after IR (P = 0.0079). Animals, which were irradiated and received MnTE-2-PyP5+ post-IR displayed significantly lower breathing rates in comparison to the IR-only group. Animals, which received late treatment starting 8 weeks post-IR displayed a trend towards elevated breathing frequencies which was not more seen 5 days after starting of treatment (implantation of pumps at day 5 of week 7; measurement of breathing frequencies five days later at day 3 of week 8).
Figure 2
Comparison of experimental groups on histopathological damage, macrophage activation (ED-1), oxidative stress (8-OHdG), transforming growth factor-β (TGF-β), hypoxia inducible factor-1α (HIF-1α), and vascular endothelial growth factor (A) (VEGF(A)). Results are displayed as vertical bar plots with standard deviation. Asterixes indicate statistical significant differences between IR-only group and IR + MnP treatment groups (p < 0.05).
Figure 3
Representative images of histotpathology (H&E staining) and Immunohistchemistry (8-OhDG, HIF-1α, VEGF (A), TGF-β, ED-1) studies. Magnification 100× for H&E, TGF-ß, VEGF(A), ED-1, Magnification 400× for 8-OHdG and HIF-1α. Groups: Control (no IR + PBS), IR + PBS (TGF-ß and HIF-1α images with 400× insert), IR + MnTE-2-PyP5+ (6 mg/kg) 2h group, IR + MnTE-2-PyP5+ 8 weeks group. Negative control shows normal lung structure, no positive (brown) immunostaining. IR + PBS shows large area of alveolar edema and cell infiltrates with beginning formation of fibrous masses and prominent immunostaining as well as activated macrophages (brown, localized interstitial and intra-alveolar). IR + MnTE-2-PyP5+ (2 h and 8 weeks groups) depict focal localized damage with thickening of alveolar wall, interstitial edema, diminished immunostaining and localized activated macrophages.
Similar articles
- Superoxide dismutase mimic, MnTE-2-PyP(5+) ameliorates acute and chronic proctitis following focal proton irradiation of the rat rectum.
Archambeau JO, Tovmasyan A, Pearlstein RD, Crapo JD, Batinic-Haberle I. Archambeau JO, et al. Redox Biol. 2013 Oct 25;1(1):599-607. doi: 10.1016/j.redox.2013.10.002. eCollection 2013. Redox Biol. 2013. PMID: 24363995 Free PMC article. - Robust rat pulmonary radioprotection by a lipophilic Mn N-alkylpyridylporphyrin, MnTnHex-2-PyP(5+).
Gauter-Fleckenstein B, Reboucas JS, Fleckenstein K, Tovmasyan A, Owzar K, Jiang C, Batinic-Haberle I, Vujaskovic Z. Gauter-Fleckenstein B, et al. Redox Biol. 2014 Jan 9;2:400-10. doi: 10.1016/j.redox.2013.12.017. eCollection 2014. Redox Biol. 2014. PMID: 24624330 Free PMC article. - Comparison of two Mn porphyrin-based mimics of superoxide dismutase in pulmonary radioprotection.
Gauter-Fleckenstein B, Fleckenstein K, Owzar K, Jiang C, Batinic-Haberle I, Vujaskovic Z. Gauter-Fleckenstein B, et al. Free Radic Biol Med. 2008 Mar 15;44(6):982-9. doi: 10.1016/j.freeradbiomed.2007.10.058. Epub 2007 Nov 21. Free Radic Biol Med. 2008. PMID: 18082148 Free PMC article. - Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics.
Batinic-Haberle I, Rajic Z, Tovmasyan A, Reboucas JS, Ye X, Leong KW, Dewhirst MW, Vujaskovic Z, Benov L, Spasojevic I. Batinic-Haberle I, et al. Free Radic Biol Med. 2011 Sep 1;51(5):1035-53. doi: 10.1016/j.freeradbiomed.2011.04.046. Epub 2011 May 6. Free Radic Biol Med. 2011. PMID: 21616142 Free PMC article. Review. - Design of Mn porphyrins for treating oxidative stress injuries and their redox-based regulation of cellular transcriptional activities.
Batinic-Haberle I, Spasojevic I, Tse HM, Tovmasyan A, Rajic Z, St Clair DK, Vujaskovic Z, Dewhirst MW, Piganelli JD. Batinic-Haberle I, et al. Amino Acids. 2012 Jan;42(1):95-113. doi: 10.1007/s00726-010-0603-6. Epub 2010 May 16. Amino Acids. 2012. PMID: 20473774 Free PMC article. Review.
Cited by
- Comprehensive pharmacokinetic studies and oral bioavailability of two Mn porphyrin-based SOD mimics, MnTE-2-PyP5+ and MnTnHex-2-PyP5+.
Weitner T, Kos I, Sheng H, Tovmasyan A, Reboucas JS, Fan P, Warner DS, Vujaskovic Z, Batinic-Haberle I, Spasojevic I. Weitner T, et al. Free Radic Biol Med. 2013 May;58:73-80. doi: 10.1016/j.freeradbiomed.2013.01.006. Epub 2013 Jan 15. Free Radic Biol Med. 2013. PMID: 23328731 Free PMC article. - MnTnHex-2-PyP5+, Coupled to Radiation, Suppresses Metastasis of 4T1 and MDA-MB-231 Breast Cancer via AKT/Snail/EMT Pathways.
Shin SW, Choi C, Kim H, Kim Y, Park S, Kim SY, Batinic-Haberle I, Park W. Shin SW, et al. Antioxidants (Basel). 2021 Nov 5;10(11):1769. doi: 10.3390/antiox10111769. Antioxidants (Basel). 2021. PMID: 34829640 Free PMC article. - Salen Mn complexes mitigate radiation injury in normal tissues.
Rosenthal RA, Fish B, Hill RP, Huffman KD, Lazarova Z, Mahmood J, Medhora M, Molthen R, Moulder JE, Sonis ST, Tofilon PJ, Doctrow SR. Rosenthal RA, et al. Anticancer Agents Med Chem. 2011 May 1;11(4):359-72. doi: 10.2174/187152011795677490. Anticancer Agents Med Chem. 2011. PMID: 21453241 Free PMC article. Review. - Temporal expression of hypoxia-regulated genes is associated with early changes in redox status in irradiated lung.
Jackson IL, Zhang X, Hadley C, Rabbani ZN, Zhang Y, Marks S, Vujaskovic Z. Jackson IL, et al. Free Radic Biol Med. 2012 Jul 15;53(2):337-46. doi: 10.1016/j.freeradbiomed.2012.04.014. Epub 2012 Apr 25. Free Radic Biol Med. 2012. PMID: 22588005 Free PMC article. - Superoxide dismutase mimic, MnTE-2-PyP(5+) ameliorates acute and chronic proctitis following focal proton irradiation of the rat rectum.
Archambeau JO, Tovmasyan A, Pearlstein RD, Crapo JD, Batinic-Haberle I. Archambeau JO, et al. Redox Biol. 2013 Oct 25;1(1):599-607. doi: 10.1016/j.redox.2013.10.002. eCollection 2013. Redox Biol. 2013. PMID: 24363995 Free PMC article.
References
- Vujaskovic Z, Anscher MS, Feng QF, Rabbani ZN, Amin K, Samulski TS, Dewhirst MW, Haroon ZA. Radiation-induced hypoxia may perpetuate late normal tissue injury. Int J Radiat Oncol Biol Phys. 2001;50:851–855. - PubMed
- Mikkelsen RB, Wardman P. Biological chemistry of reactive oxygen and nitrogen and radiation-induced signal transduction mechanisms. Oncogene. 2003;22:5734–5754. - PubMed
- Leach JK, Van Tuyle G, Lin PS, Schmidt-Ullrich R, Mikkelsen RB. Ionizing radiation-induced, mitochondria-dependent generation of reactive oxygen/nitrogen. Cancer Res. 2001;61:3894–3901. - PubMed
- Pearce LL, Epperly MW, Greenberger JS, Pitt BR, Peterson J. Identification of respiratory complexes I and III as mitochondrial sites of damage following exposure to ionizing radiation and nitric oxide. Nitric Oxide. 2001;5:128–136. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 CA098452/CA/NCI NIH HHS/United States
- U19 AI067798/AI/NIAID NIH HHS/United States
- R01 CA 098452/CA/NCI NIH HHS/United States
- U19-AI-067798/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous